Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 20 New Entrants companies in Nicotinamide mononucleotide
by Most Patent Filing In 1 Year in the world in 2021

The Nicotinamide mononucleotide top 20 is Discovery PatSnap’ annual ranking of the top 20 Most Patent Filing In 1 Year Nicotinamide mononucleotide New Entrants in the world. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2021, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Nicotinamide mononucleotide ("NMN", "NAMN", and "β-NMN") is a nucleotide derived from ribose and nicotinamide. Like nicotinamide riboside, NMN is a derivative of niacin, and humans have enzymes that can use NMN to generate nicotinamide adenine dinucleotide (NADH).
#
Company Name
Region
Tech Topics
Total
1
Medicine,Bead,Cardiovascular agent,
...[+2]
Patent: 3
2
Japan
Patent: 2
3
Patent: 2
4
Tokyo, Japan
Patent: 2
5
Patent: 1
6
Patent: 1
7
California, United States
Patent: 1
8
Patent: 1
9
Health care,Research system,International health,
...[+2]
Patent: 1
10
Hiroshima, Japan
Educational institution,Test-driven development,5G,
...[+2]
Patent: 1
11
Massachusetts, United States
Patent: 1
12
Economic globalization,Monoclonal antibody,Biopharmaceutical,
...[+2]
Patent: 1
13
Patent: 1
14
Patent: 1
15
Plasma Volume Expander,Antibiotics,Drug,
...[+1]
Patent: 1
16
Patent: 1
17
Patent: 1
18
Patent: 1
19
Patent: 1
20
Patent: 1
Page generation time: Jun 20 2025